NAJ decided to pursue A2 research with two primary goals: 1. To determine if there is a quantifiable benefit to consumers from A2 and/or Jersey milks. 2. If so, to determine the threshold of A2 at which the benefit can be realized. In other words, does milk need to be 100% A2, or will milks of lesser amounts of A2 also provide benefits. The research project was led by Dr. Dennis Savaiano and involved clinical trials with persons known to be lactose maldigesters due to problematic digestive symptoms experienced after ingesting lactose. The A2 Milk Company was also interested in this research which led to NAJ and the A2 Milk Company jointly funding the research project, “Comparing the digestion of milk with different beta-casein protein content in lactose maldigesters.”